基于Beers标准的合理用药审查工具干预对社区老年慢性病病人的效果评价

张瑞辉; 陈小英; 李伙桂; 黄学勤; 黎婉红; 陈燕平

doi:10.13898/j.cnki.issn.1000-2200.2017.03.032

基于Beers标准的合理用药审查工具干预对社区老年慢性病病人的效果评价

1. 广东省云浮市人民医院药学部, 527300;
2. 广东省云浮市人民医院综合科, 527300;
3. 广东省云浮市人民医院消化肾内科, 527300

基金项目:

广东省云浮市卫生医药科研立项（2015B24）

详细信息

作者简介:
张瑞辉(1983-),男,主管药师.

中图分类号: R95
计量
- 文章访问数: 3651
- HTML全文浏览量: 428
- PDF下载量: 87
出版历程
- 收稿日期: 2016-04-10

Evaluation of the effect of the review tool intervention on the reasonable medication in community senile patients with chronic diseases

1. Department of Pharmaceutical Science, The People's Hospital of Yunfu, Yunfu Guangdong 527300, China;
2. Integrated Sector, The People's Hospital of Yunfu, Yunfu Guangdong 527300, China;
3. Department of Urology, The People's Hospital of Yunfu, Yunfu Guangdong 527300, China

摘要

摘要: 目的：基于Beers标准，对社区老年慢性病病人实施合理用药审查工具干预的效果进行评价。方法：随机选择某社区老年慢性病病人200例，按照随机数字表法分为干预组103例和对照组97例。对照组病人接受常规用药指导，干预组病人基于Beers标准接受合理用药审查工具干预。观察并比较2组病人用药情况。结果：2组病人干预前药物治疗收益情况和生命健康质量各项指标差异均无统计学意义（P>0.05）。干预后，干预组病人药物不良反应、用药数量和用药费用均明显少于对照组（P<0.01），而依从性显著优于对照组（P<0.01），2组病人超适应症用药差异无统计学意义（P>0.05）；干预组病人生命健康质量各项评价指标亦均优于对照组（P<0.05~P<0.01）。结论：基于Beers标准，在社区老年慢性病病人中实施合理用药审查工具干预，不仅用药安全有效，同时也减轻病人经济负担，并有利于病人生命健康质量的提升，具有进一步推广价值。
- 慢性病 /
- 社区 /
- 老年 /
- 合理用药 /
- Beers标准
Abstract: Objective:To evaluate the effects of the review tool intervention on the reasonable medication in community senile patients with chronic diseases based on Beers standard.Methods:Two hundred community senile patients with chronic diseases were randomly selected,and divided into the control group(103 cases) and intervention group(97 cases).The control group were instructed with routine medication,and the intervention group were instructed with the review tool intervention of the reasonable medication based on the Beers standard.The medication between two groups was compared.Results:The differences of the benefit of medication and indicators of life quality before intervention between two groups were not statistically significant(P>0.05).After intervention,the adverse reactions,amount and cost of medication in intervention group were significantly less than those in control group(P<0.01),but the compliance of medication in intervention group was significantly better than that in control group(P<0.01).The difference of the super indications medication between two groups was not statistically significant(P>0.05).The indicators of life quality in intervention group was better than that in control group(P<0.05 to P<0.01).Conclusions:The review tool intervention of the reasonable medication in community senile patients with chronic diseases based on Beers standard is safe and effective,which can lighten the financial burden and improve the quality of life and health of patients,and is worth popularizing.
- chronic disease /
- community /
- elderly /
- rational administration /
- Beers standard

HTML全文

参考文献(11)

[1]	郭梅花.社区老年慢性病人用药特点和对策[J].医药前沿,2014,6(8):56.
[2]	罗玉玲,谭颖芬,陈少梅,等.神经内科老年患者口服药护理危机分析及对策[J].临床心身疾病杂志,2013,19(2):191.
[3]	唐晶,周艳,张毓,等.城乡社区老年人盲目用药及保健品的调查分析[J].中国全科医学,2014,17(16):1906.
[4]	孟锐.药事管理概论[M].北京:中国医药科技出版社,2012:116.
[5]	赵慧楠,戴付敏,张希,等.社区居家和养老机构老年人用药安全影响因素及对策[J].中国实用护理杂志,2014,30(1):4.
[6]	欧阳林雅.常见老年慢性病用药分析及对策[J].中国医药科学,2013,8(6):129.
[7]	马维红,李琦,杨晓玲,等.桂林市漓东社区老年慢性病用药调查及健康管理模式探讨[J].中国医院用药评价与分析,2011,11(8):757.
[8]	彭晓晔.社区老年慢性病人用药特点与对策[J].中国执业药师,2010,7(10):13.
[9]	沈杰,刘奕芳,高宁舟,等.Beers判断标准在老年住院患者潜在性不适当用药评价中的应用[J].中国药房,2010,21 (6):556.
[10]	蹇在金.老年人不宜使用的药物[J].中国实用内科杂志,2011,2(1):17.
[11]	葛剑力,翟晓波,邵莉,等.合理用药监测系统在老年患者中的防范效应[J].中华老年多器官疾病杂志,2010,9(2):114.

施引文献(5)

期刊类型引用(2)

1.	吴秀兰. 老年人社区合理用药管理的必要性探讨. 中国卫生产业. 2018(13): 38-39 . 百度学术
2.	邹晶晶. 老年人常见药物不良反应及合理用药的临床分析. 中国医药指南. 2018(24): 91-92 . 百度学术